"We are confident that rotating bed reactors will be pivotal in successfully remedying PFAS-contaminated sites" says Emil Byström, CEO of SpinChem about their contribution to the Beat-PFAS project.
"We are confident that rotating bed reactors will be pivotal in successfully remedying PFAS-contaminated sites" says Emil Byström, CEO of SpinChem about their contribution to the Beat-PFAS project.

Press release -

SpinChem plays crucial role in SEK 19 million PFAS-project

The "Beat-PFAS" project aims to develop an effective solution for removing and destroying PFAS (per- and polyfluoroalkyl substances) from contaminated soil and water. The Umeå based company SpinChem AB is set to play a crucial role in this initiative, funded by Formas, a Swedish government research council dedicated to sustainable development, with a grant of SEK 19.9 million.

The project, led by Professor Jurate Kumpiene at the Luleå University of Technology (LTU), focuses on breaking the cycle of environmental contamination by PFAS, a group of harmful chemicals.

As part of the project, SpinChem's RBR technology will be integrated into a complete solution for treating contaminated soils. This innovative technology enables rapid removal of a wide range of PFAS compounds, contributing to the project's overall goals.

"We are excited to be a part of the Beat-PFAS project and to contribute our expertise in developing solutions for the global process chemical industry," said Emil Byström, CEO of SpinChem AB. "Our rotating bed reactors have already demonstrated significant potential in simultaneously removing anions and cations, and we are confident that they will be pivotal in successfully remedying PFAS-contaminated sites."

The Beat-PFAS project also presents exciting collaboration opportunities for SpinChem, a company driven by innovation and sustainability.

"It's thrilling to collaborate with key players like LTU, Luleå Environmental Resources (Lumire), and Nova Diamant AB, as we work together to develop a cost-effective and environmentally friendly solution for the PFAS challenge," concluded Emil Byström.

In its latest funding round titled "Blue Innovation – Implementation Projects," Formas has allocated 166 million SEK to ten projects.

About SpinChem AB
SpinChem AB is a privately owned company headquartered in Umeå, Sweden. Specializing in the development of Rotating Bed Reactors (RBR) for synthesis and purification in the chemical and biotechnical industries, SpinChem AB continues to innovate and contribute to sustainable process chemistry, driven by a vision to change the world with simple, fast, stable, and resource-efficient technological solutions.

For more information, please contact:
Emil Byström, CEO, SpinChem AB
Telephone: +46 706 892 501
E-mail: emil@spinchem.com
Webbp: www.spinchem.com

Topics

Categories

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Contacts

Tomas Ruuth

Tomas Ruuth

Press contact Head of PR & Communications PR & Communications 072-4024697 www.ubi.se

Related media

Download images for media use

Related content

Martin Lundin sees enormous potential in Spinchem: "They combines fascinating cutting-edge technology with talented employees" he says.

Former Perstorp CEO becomes Spinchem AB’s new Chairman of the Board

The former CEO of chemical industry giant Perstorp Martin Lundin has been appointed Chairman of the Board for Umeå-based Spinchem AB. “Spinchem combines fascinating cutting-edge technology with talented employees while operating in an exciting market”, says Martin Lundin.

Emil Byström, third from the left, together with representatives from companies in the Enzyme Technology Alliance.

SpinChem joins trailblazing alliance: "We can make a difference in the world"

The Umeå company SpinChem has joined the Enzyme Technology Alliance, a group of six European companies collaborating to bring competitive solutions to the biotech industry. CEO Emil Byström states the alliance can offer solutions unimaginable before, aiming to replace harmful processes with environmentally friendly alternatives and contribute to a more sustainable industry.

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden

ubi.se
Umeå Biotech Incubator Enter your email address to follow Umeå Biotech Incubator

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Umeå Biotech Incubator Check your inbox

Email sent to __email__. Click the link there to follow Umeå Biotech Incubator.

Okay